{
    "SPADE_UN_19046": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_19046",
            "Peptide Name": "Z2 (Synthetic AMPs, Ile-rich, Arg-rich, UCLL1; BBN; Z1, MIC>64 ug/ml)",
            "Source": "De novo designed, man-made sequences",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "RKIIRRIIPIIRRIIKR",
            "Sequence Length": 17,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2213.85,
            "PI": 12.0,
            "Hydrophobicity": -0.02,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Zhang MY, Li S, Han YL, Shi YF, Wu YY, Cheng J, Wang CY, Zhou XY, Zhang YX. 2025",
                    "Reference": "Bioorg Chem. 2025 Feb 22;157:108309. doi: 10.1016/j.bioorg.2025.108309.PubMed",
                    "Title": "De novo-designed amphiphilic alpha-helical peptide Z2 exhibits broad-spectrum antimicrobial, anti-biofilm, and anti-inflammatory efficacy in acute Pseudomonas aeruginosa pneumonia."
                }
            ],
            "Frequent Amino Acids": "IRK",
            "Absent Amino Acids": "ACDEFGHLMNOQSTUVWY",
            "Basic Residues": 8,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 8,
            "Positive Residues": 8,
            "Negative Residues": 0,
            "Net Charge": 8,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar to (58.82%) todesigned GNU6I: 47%, R: 35%, K: 12%.Activity: active against 4 strains E. coli ATCC 9637 or SYP-B3820/B4288/B4289 (MIC 2-8 ug/ml), 3 strains A. baumannii SYP-B4290/B4291/B3819 (MIC 4-8 ug/ml), S. paratyphi ATCC 14028 (MIC 4 ug/ml), K. pneumoniae CMCC46117 (MIC 4 ug/ml), and P. aeruginosa ATCC 9027 (MIC 4 ug/ml).Warning: only Gram- bacteria were tested.Structure: more helical in SDS than in TFE.In vitro toxicity: 0.14% hemolysis at 128 ug/ml, HC50>100 ug/ml, poorly hemo.lytic.Antimicrobial robustness: NaCl-insensitive:P. aeruginosa, KCl-insensitive:P. aeruginosa, MgCl2-insensitive:P. aeruginosa, FeCl3-insensitive:P. aeruginosa, NH4Cl-insensitive:P. aeruginosa, CaCl2-insensitive:P. aeruginosa,   serum-insensitive (50%).Peptide stability:  cleaved by trypsin, cleaved by chymotrypsin.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_04584",
                    "Similarity": 1.0,
                    "Sequence": "RGRKIIRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_04593",
                    "Similarity": 1.0,
                    "Sequence": "RGRKIIRR"
                },
                {
                    "SPADE_ID": "SPADE_N_12887",
                    "Similarity": 1.0,
                    "Sequence": "IIRRIRRII"
                }
            ]
        }
    }
}